A second pathway for modulating glucocorticoid receptor transactivation properties

Molecular and Cellular Endocrinology

Volumn 199, Issue 1-2, 2003, Pages 129-142

  Chen, Shiyou ^a,b   Simons Jr , S Stoney ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

E1A; Glucocorticoid receptor; hSur2; Modulation of dose response curve; Partial agonist activity

Indexed keywords

CIS ACTING ELEMENT; DEXAMETHASONE; DEXAMETHASONE DERIVATIVE; GLUCOCORTICOID; GLUCOCORTICOID ANTAGONIST; GLUCOCORTICOID RECEPTOR; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN DERIVATIVE; PROTEIN E1A 133C; PROTEIN SUR2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSACTIVATION;

ADENOVIRUS E1A PROTEINS; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PEPTIDE FRAGMENTS; POINT MUTATION; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0037474146     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00333-7     Document Type: Article

References (66)

1. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
2. Asturias F.J., Jiang Y.W., Myers L.C., Gustafsson C.M., Kornberg R.D. Conserved structures of mediator and RNA polymerase II holoenzyme. Science. 283:1999;985-987.
3. Baulieu E.E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science. 245:1989;1351-1357.
4. Beato M., Chavez S., Truss M. Transcriptional regulation by steroid hormones. Steroids. 61:1996;240-251.
5. Berry M., Metzger D., Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
6. Boyer T.G., Martin M.E.D., Lees E., Ricciardi R.P., Berk A.J. Mammalian Srb/mediator complex is targeted by adenovirus E1A protein. Nature. 399:1999;276-279.
7. Chakravarti D., Ogryzko V., Kao H.-Y., Nash A., Chen H., Nakatani Y., Evans R.M. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell. 96:1999;393-403.
8. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
9. Chen S., Sarlis N.J., Simons S.S. Jr. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription. J. Biol. Chem. 275:2000;30106-30117.
10. Chiba N., Suldan Z., Freedman L.P., Parvin J.D. Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme. J. Biol. Chem. 275:2000;10719-10722.
11. Collier C.D., Oshima H., Simons S.S. Jr. A negative tyrosine aminotransferase gene element that blocks glucocorticoid modulatory element-regulated modulation of glucocorticoid-induced gene expression. Mol. Endocrinol. 10:1996;463-476.
12. Crawford E.D., Eisenberger M.A., McLeod D.G., Spaulding J.T., Benson R., Dorr F.A., Blumenstein B.A., Davis M.A., Goodman P.J. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. New Engl. J. Med. 321:1989;419-424.
13. Eckner R., Ewen M.E., Newsome D., Gerdes M., DeCaprio J.A., Lawrence J.B., Livingston D.M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300 kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:1994;869-884.
14. Flint J., Shenk T. Viral transactivating proteins. Annu. Rev. Genet. 31:1997;177-212.
15. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. USA. 93:1996;8329-8333.
16. Giannoukos G., Szapary D., Smith C.L., Meeker J.E.W., Simons S.S. Jr. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties. Mol. Endocrinol. 15:2001;255-270.
17. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcription functions of nuclear receptors. Genes Dev. 14:2000;121-141.
18. Heinzel T., Lavinsky R.M., Mullen T.-M., Söderström M., Laherty C.D., Torchia J., Yang W.-M., Brard G., Ngo S.D., Davie J.R., Seto E., Eisenman R.N., Rose D.W., Glass C.K., Rosenfeld M.G. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature. 387:1997;43-48.
19. Hong H., Kohli K., Trivedi A., Johnson D.L., Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA. 93:1996;4948-4952.
20. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Glass C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
21. Huang N., vom Baur E., Garnier J.M., Lerouge T., Vonesch J.L., Lutz Y., Chambon P., Losson R. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. EMBO J. 17:1998;3398-3412.
22. Ito M., Yuan C.X., Malik S., Gu W., Fondell J.D., Yamamura S., Fu Z.Y., Zhang X., Qin J., Roeder R.G. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell. 3:1999;361-370.
23. Jackson D.A., Collier C.D., Oshima H., Simons S.S. Jr. Modulation of tat gene induction by glucocorticoids involves a neutralizing sequence. J. Steroid Biochem. Mol. Biol. 66:1998;79-91.
24. Jenster G., Spencer T.E., Burcin M.M., Tsai M.T., O'Malley B.W. Steroid receptor induction of gene transcription: a two step model. Proc. Natl. Acad. Sci. USA. 94:1997;7879-7884.
25. Jones P.L., Sachs L.M., Rouse N., Wade P.A., Shi Y.B. Multiple N-CoR complexes contain distinct histone deacetylases. J. Biol. Chem. 276:2001;8807-8811.
26. Jordan V.C., Murphy C.S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocrinol. Rev. 11:1990;578-610.
27. Kaul S., Blackford J.A. Jr, Chen J., Ogryzko V.V., Simons S.S. Jr. Properties of the glucocorticoid modulatory element binding proteins GMEB-1 and -2: potential new modifiers of glucocorticoid receptor transactivation and members of the family of KDWK proteins. Mol. Endocrinol. 14:2000;1010-1027.
28. Lamontagne N., Mercier L., Pons M., Thompson E.B., Simons S.S. Jr. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity. Endocrinology. 114:1984;2252-2263.
29. Maldonado E., Shiekhattar R., Sheldon M., Cho H., Drapkin R., Rickert P., Lees E., Anderson C.W., Linn S., Reinberg D. A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature. 381:1996;86-89.
30. Mathur M., Tucker P.W., Samuels H.H. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol. Cell. Biol. 21:2001;2298-2311.
31. McKenna N.J., Nawaz Z., Tsai S.Y., Tsai M.-J., O'Malley B.W. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;11697-11702.
32. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocrinol. Rev. 20:1999;321-344.
33. Mercier L., Thompson E.B., Simons S.S. Jr. Dissociation of steroid binding to receptors and steroid induction of biological activity in a glucocorticoid responsive cell. Endocrinology. 112:1983;601-609.
34. Mercier L., Miller P.A., Simons S.S. Jr. Antiglucocorticoid steroids have increased agonist activity in those hepatoma cell lines that are more sensitive to glucocorticoids. J. Steroid Biochem. 25:1986;11-20.
35. Myer V.E., Young R.A. RNA polymerase II holoenzymes and subcomplexes. J. Biol. Chem. 273:1998;27757-27760.
36. Naar A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W., Tjian R. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature. 398:1999;828-832.
37. Neish A.S., Anderson S.F., Schlegel B.P., Wei W., Parvin J.D. Factors associated with the mammalian RNA polymerase II holoenzyme. Nucleic Acids Res. 26:1998;847-853.
38. Ogryzko V.V., Kotani T., Zhang X., Schlitz R.L., Howard T., Yang X.J., Howard B.H., Qin J., Nakatani Y. Histone-like TAFs within the PCAF histone acetylase complex. Cell. 94:1998;35-44.
39. Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
40. Oshima H., Simons S.S. Jr. Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density. Endocrinology. 130:1992;2106-2112.
41. Oshima H., Simons S.S. Jr. Modulation of transcription factor activity by a distant steroid modulatory element. Mol. Endocrinol. 6:1992;416-428.
42. Oshima H., Simons S.S. Jr. Sequence-selective interactions of transcription factor elements with tandem glucocorticoid-responsive elements at physiological steroid concentrations. J. Biol. Chem. 268:1993;26858-26865.
43. Oshima H., Szapary D., Simons S.S. Jr. The factor binding to the glucocorticoid modulatory element of the tyrosine aminotransferase gene is a novel and ubiquitous heteromeric complex. J. Biol. Chem. 270:1995;21893-21910.
44. Ossipow V., Tassan J.P., Nigg E.A., Schibler U. A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation. Cell. 83:1995;137-146.
45. Pan G., Aso T., Greenblatt J. Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activators. J. Biol. Chem. 272:1997;24563-24571.
46. Plisov S.Y., Poirot M.E., Modarress K.J., Cavanaugh A.H., Edwards D.P., Simons S.S.J. Different populations of progesterone receptor-steroid complexes in binding to specific DNA sequences: effects of salts on kinetics and specificity. J. Steroid Biochem. Mol. Biol. 67:1998;251-266.
47. Pons M., Simons S.S. Jr. Facile, high yield synthesis of spiro C-17-steroidal oxetan-3′-ones. J. Org. Chem. 46:1981;3262-3264.
48. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature. 398:1999;824-828.
49. Reichardt H.M., Umland T., Bauer A., Kretz O., Schutz G. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell. Biol. 20:2000;9009-9017.
50. Robyr D., Wolffe A.P., Wahli W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol. Endocrinol. 14:2000;329-347.
51. Sarlis N.J., Bayly S.F., Szapary D., Simons S.S. Jr. Quantity of partial agonist activity for antiglucocorticoids complexed with mutant glucocorticoid receptors is constant in two different transactivation assays but not predictable from steroid structure. J. Steroid Biochem. Mol. Biol. 68:1999;89-102.
52. Sharma M., Zarnegar M., Li X., Lim B., Sun Z. Androgen receptor interacts with a novel MYST protein, HBO1. J. Biol. Chem. 275:2000;35200-35208.
53. Simons S.S. Jr, Pons M., Johnson D.F. a-Keto mesylate: a reactive thiol-specific functional group. J. Org. Chem. 45:1980;3084-3088.
54. Simons S.S. Jr, Oshima H., Szapary D. Higher levels of control: modulation of steroid hormone-regulated gene transcription. Mol. Endocrinol. 6:1992;995-1002.
55. Song L.-N., Huse B., Rusconi S., Simons S.S. Jr. Transactivation specificity of glucocorticoid versus progesterone receptors: role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains. J. Biol. Chem. 276:2001;24806-24816.
56. Szapary D., Xu M., Simons S.S. Jr. Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration. J. Biol. Chem. 271:1996;30576-30582.
57. Szapary D., Huang Y., Simons S.S. Jr. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor regulated gene expression. Mol. Endocrinol. 13:1999;2108-2121.
58. Tsai M.-J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
59. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.B., Pike J.W., McDonnell D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
60. Vayssiere B.M., Dupont S., Choquart A., Petit F., Garcia T., Marchandeau C., Gronemeyer H., Resche-Rigon M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol. Endocrinol. 11:1997;1245-1255.
61. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. T1F2, a 160 kDa transcriptional mediatior for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
62. Voegel J.J., Heine M.J.S., Tini M., Vivat V., Chambon P., Gronemeyer H. The coactivator T1F2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17:1998;507-519.
63. Wang G., Cantin G.T., Stevens J.L., Berk A.J. Characterization of mediator complexes from HeLa cell nuclear extract. Mol. Cell. Biol. 21:2001;4604-4613.
64. Wasner G., Oshima H., Thompson E.B., Simons S.S. Jr. Unlinked regulation of the sensitivity of primary glucocorticoid-inducible responses in mouse mammary tumor virus infected Fu5-5 rat hepatoma cells. Mol. Endocrinol. 2:1988;1009-1017.
65. Webster L.C., Ricciardi R.P. Trans-dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor. Mol. Cell. Biol. 11:1991;4287-4296.
66. Zeng H., Plisov S.Y., Simons S.S. Jr. Ability of the glucocorticoid modulatory element (GME) to modify glucocorticoid receptor transactivation indicates parallel pathways for the expression of GME and glucocorticoid response element activities. Mol. Cell. Endocrinol. 162:2000;221-234.